By clarifying what evidence it needs before it will pay for medicines like Aduhelm, health officials paved the way for improved drug innovation.
Medicare Is Cleaning Up the FDA’s Mess on Biogen’s Alzheimer’s Drug
The First and Last Word in News
The First and Last Word in News
By clarifying what evidence it needs before it will pay for medicines like Aduhelm, health officials paved the way for improved drug innovation.